Amicus Therapeutics FOLD reported its Q3 earnings results on Monday, November 7, 2022 at 06:12 AM.
Here's what investors need to know about the announcement.
Amicus Therapeutics beat estimated earnings by 36.84%, reporting an EPS of $-0.12 versus an estimate of $-0.19.
Revenue was up $2.15 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 11.33% increase in the share price the next day.
Here's a look at Amicus Therapeutics's past performance:
|Quarter||Q2 2022||Q1 2022||Q4 2021||Q3 2021|
To track all earnings releases for Amicus Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.